Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 5,900
- Avg volume
- 1,744
- Day's range
- $0.86 – $0.90
- Shares out
- —
- Stochastic %K
- 96%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- (888) 436 7772
- Website
- https://www.lirlifesciences.com
- Address
- 1505 W 2nd Ave, Suite 506, Vancouver, Canada
Latest news
No headlines yet.
